1. Approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2025 prepared in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 together with the Limited Review Report of the Statutory Auditors are enclosed herewith (annexed as Annexure I). 2. Approved the Appointment of Dr. Aravind Kumar Madala (DIN: 06994824) as an Additional Director designated as the Managing Director with effect from 1st September, 2025 subject to the approval of the Shareholders.